Shanghai Jiao Tong University partners with Ant Health to establish a medical laboratory, and the Sci-Tech Innovation Medical ETF Huaxia(588130) is receiving significant market attention.

2026-04-04 18:12:48

As of April 3, 2026, 11:20, the SSE STAR Market biopharmaceutical index (000683) fell 2.48%. By constituent stocks, Chengdu Xianzhida led the decline by 5.61%, followed by Hotgen Biotech down 5.26%, Sinno Medical down 5.07%, Olin Biotech down 4.59%, and Nuowei Zan down 4.39%. The Huaxia STAR Market Biopharma ETF (588130) fell 2.62%, with a latest quote of 1.08 yuan.

In terms of news, according to Ant Group, recently, the School of Artificial Intelligence at Shanghai Jiao Tong University and Ant Health signed a cooperation agreement to jointly launch the “AI4Health Care Joint Laboratory,” working together on joint breakthroughs in R&D of specialized agents in the healthcare sector, clinical-adaptation applications, and more.

According to data from Southwest Securities, in 2025 Q4, public funds’ overall holdings in the pharmaceutical sector declined quarter over quarter, but there were clear structural increases: the holdings allocation in the medical research outsourcing (CXO) sub-industry reached 9.62%, up 0.46 percentage points quarter over quarter, the largest increase among all sub-industries. Among the top five by total market value of fund holdings were Innovent Biologics, Shanghai Fosun Pharmaceutical/Pharma (CSPC?), Xinda Biological, Mindray Medical, and Kangfang Bio. The top three by added market value for the quarter were Tigermed, Yingen Bio-B, and Hansoh Pharmaceutical, reflecting institutions’ continued optimism toward STAR Market-style biopharmaceutical companies with global R&D capabilities and the potential to realize clinical-data value.

On liquidity, during trading hours, the Huaxia STAR Market Biopharma ETF recorded a turnover rate of 4.76%, with trading volume of 2.9155 million yuan. Looking over a longer period, as of April 2, the Huaxia STAR Market Biopharma ETF’s average daily turnover over the past week was 9.4516 million yuan.

Data shows that as of March 31, 2026, the top ten weight stocks of the SSE STAR Market biopharmaceutical index (000683) were United Imaging Healthcare, BeiGene, Aileris, Biolitec/BeiGene? (Aries?), Rongchang Biotech, Haitai? (Huatai Medical?), Junshi Biosciences, Zhej ing? (Zejing Pharma?), Borui Medical, and iRe? (Yirui Technology). The combined share of the top ten weight stocks was 48.91%.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.